Solana Company (NASDAQ:HSDT) Short Interest Up 71.1% in December

Solana Company (NASDAQ:HSDT) was the target of a large increase in short interest during the month of December. As of December 31st, there was short interest totaling 963,146 shares, an increase of 71.1% from the December 15th total of 562,864 shares. Approximately 2.8% of the company’s shares are short sold. Based on an average trading volume of 633,610 shares, the short-interest ratio is currently 1.5 days. Based on an average trading volume of 633,610 shares, the short-interest ratio is currently 1.5 days. Approximately 2.8% of the company’s shares are short sold.

Institutional Inflows and Outflows

An institutional investor recently bought a new position in Solana stock. Grant Private Wealth Management Inc purchased a new stake in shares of Solana Company (NASDAQ:HSDT) during the 4th quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The fund purchased 15,805 shares of the company’s stock, valued at approximately $46,000. 18.63% of the stock is currently owned by institutional investors.

Analyst Ratings Changes

HSDT has been the subject of several recent analyst reports. Wall Street Zen raised shares of Solana from a “sell” rating to a “hold” rating in a research note on Saturday, November 22nd. Weiss Ratings reaffirmed a “sell (e+)” rating on shares of Solana in a research report on Wednesday, October 8th. One research analyst has rated the stock with a Sell rating, Based on data from MarketBeat.com, the stock has an average rating of “Sell”.

Solana Stock Down 11.2%

Shares of NASDAQ:HSDT traded down $0.39 on Thursday, hitting $3.10. The company had a trading volume of 309,881 shares, compared to its average volume of 512,668. The firm’s 50-day simple moving average is $3.61 and its two-hundred day simple moving average is $7.47. The firm has a market capitalization of $128.03 million, a price-to-earnings ratio of 0.00 and a beta of 1.03. Solana has a 1 year low of $2.62 and a 1 year high of $1,200.00.

Solana (NASDAQ:HSDT) last released its quarterly earnings results on Tuesday, November 18th. The company reported ($32.89) earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of ($50.50) by $17.61. Solana had a negative net margin of 39,358.88% and a negative return on equity of 699.93%. The company had revenue of $0.70 million during the quarter, compared to the consensus estimate of $0.11 million.

Solana Company Profile

Helius Medical Technologies, Inc (NASDAQ: HSDT) is a medical technology company focused on developing and commercializing non‐invasive neuromodulation platforms designed to enhance neurorehabilitation. Its flagship product, the Portable Neuromodulation Stimulator (PoNS®), delivers mild electrical pulses to the tongue to stimulate neural pathways in conjunction with targeted physical therapy. The device is intended to improve neuroplasticity and support recovery in patients with neurological conditions.

The PoNS system is cleared for use in the United States, Canada and the European Union and is prescribed through specialized rehabilitation clinics.